Grant: Project Grant
University of Toronto
$100,000.00
Targeting protein arginine methylation in tumor-associated macrophages
FY 2022-23
Summary
Modulating the posttranscriptional modification of arginine methylation through targeting the protein arginine protein methyltransferase (PRMT) enzymes is a promising approach in cancer therapeutics. PRMT directed drugs have been shown to be effective in several preclinical cancer models and are currently undergoing evaluation in clinical trials. However how modulating PRMTs affects the immune system is not well understood. This is important because immune system plays a critical role in eradicating cancer. We will investigate how PRMT enzymes control the innate immune system myeloid cell function. The outcomes of this work will help us understand how we can effectively small molecule PRMT targeting drugs in cancer treatment.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
477308
Name
Barsyte-Lovejoy Dalia
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cancer Biology & Therapeutics
Projecttitle
Targeting protein arginine methylation in tumor-associated macrophages
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Posttranslational Modifications; Splicing; Tumor Immunity
Abstract
Modulating the posttranscriptional modification of arginine methylation through targeting the protein arginine protein methyltransferase (PRMT) enzymes is a promising approach in cancer therapeutics. PRMT directed drugs have been shown to be effective in several preclinical cancer models and are currently undergoing evaluation in clinical trials. However how modulating PRMTs affects the immune system is not well understood. This is important because immune system plays a critical role in eradicating cancer. We will investigate how PRMT enzymes control the innate immune system myeloid cell function. The outcomes of this work will help us understand how we can effectively small molecule PRMT targeting drugs in cancer treatment.
Competitiondate
202210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Barsyte-Lovejoy, Dalia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~